Tenet Healthcare (THC) Tops Q3 Earnings and Revenue Estimates

Core Insights - Tenet Healthcare (THC) reported quarterly earnings of $3.7 per share, exceeding the Zacks Consensus Estimate of $3.33 per share, and up from $2.93 per share a year ago, representing an earnings surprise of +11.11% [1] - The company achieved revenues of $5.29 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.02% and showing an increase from $5.12 billion year-over-year [2] - Tenet shares have increased approximately 71.3% year-to-date, significantly outperforming the S&P 500's gain of 16.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $4.13 on revenues of $5.39 billion, and for the current fiscal year, it is $15.82 on revenues of $21.16 billion [7] - The estimate revisions trend for Tenet was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Hospital industry, to which Tenet belongs, is currently ranked in the top 16% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]